您当前的位置:国际号刊-月刊 > 化学 > 生物科学 >
化学工程与生物工程(英文)(Chem & Bio Engineering)(国际刊号)(2026年12月31日之前不收版面费)

化学工程与生物工程(英文)(Chem & Bio Engineering)(国际刊号)(2026年12月31日之前不收版面费)

基本信息
  • 主管单位:

  • 主办单位:

    浙江大学和美国化学会

  • 国际刊号:

    2836-967X

  • 国内刊号:

  • 学科分类:

  • 字数:

    -

  • 有无基金:

     

  • 周期:

    国际号刊-月刊

  • 特殊属性:

    外文期刊

联系信息
  • 电话:

  • 邮箱:

    eic@cbe.acs.org(主编)(官网邮箱)

  • 复合因子:

    0

  • 综合因子:

    0

  • 收录:

  • 级别:

期刊简介

《化学工程与生物工程(英文)(Chem & Bio Engineering)(国际刊号)(2026年12月31日之前不收版面费)》期刊已被查看:

更新频次

单位占比

一作占比

投稿指南

1、该刊只有国际刊号!

2、投稿方式:在线投稿。

3、官网网址:https://pubs.acs.org/page/cbehb5

(微信公众号信息)

4、投稿系统:https://acs.manuscriptcentral.com/acs

5、官网邮箱:eic@cbe.acs.org(主编)

(更多编辑邮箱请查看期刊官网信息)

6、出刊日期:月刊,每月出版一期。

7、官网信息:2026年12月31日之前不收版面费。

2023年8月30星期三

Chem & Bio Engineering 已正式开放投稿

【微信公众号“浙大化工”信息】

浙大化工 2023-08-24

由浙江大学和美国化学会出版部合作出版的高定位新刊Chem & Bio Engineering (《化学工程与生物工程》)已正式开放投稿。敬请关注和投稿。

关于Chem & Bio Engineering

Chem & Bio Engineering旨在发表化学工程和生物工程领域的前沿科学。该期刊聚焦于催化、分离工程、合成与工艺过程智能优化、生物医学材料、合成生物学、储能材料、环境管理等重要领域的机遇与挑战,为发展高效可持续的工程方案提供高水平的国际学术交流平台。期刊将涵盖多种类型文章,包括Research Article,Letter,Review,Perspective,Viewpoint,Commentary 和Editorial 。

开放投稿:2023年8月22日

首年接受发表的文章免收文章出版费(APC)

发文范畴

Chem & Bio Engineering的发表范围包括但不限于:

Advanced Catalysis Engineering

Advanced Separation

Advanced Synthesis and Scalable Processes

Biomedical Engineering and Synthetic Biology

Materials Engineering

Sustainable Engineering

所有的稿件都将经过严格、公平、高效的同行评审流程。我们致力于发表高质量的论文,以此来赢得学者的信任。如有任何疑问,请发送电子邮件至: eic@cbe.acs.org。

期刊主页:

https://pubs.acs.org/journal/cbehb5

作者指南Author Guidelines

【官网信息】

Author Guidelines

Scope Of The Journal

Chem & Bio Engineering is a peer-reviewed, open-access journal that publishes significant advances in various aspects of chemical and biological engineering.

The field of chemical and biological engineering faces emerging challenges of developing efficient and sustainable solutions in areas such as manufacturing, energy, environmental stewardship, and healthcare. In this regard, Chem & Bio Engineering aims to be a premier journal for chemical and biological engineers to share and discuss innovative and inspirational research that seeks to address these multifaceted challenges.

More information can be found here.

Manuscript Types

Article

Articles should report a significant advance in the field of chemical and biological engineering, being characterized by the editor and referees as in the top 10% of advances in the field. Articles must exhibit high scientific quality, originality, significance, and conceptual novelty. They are not intended to be follow-up papers, unless they contain new and extensive information that will substantially advance the understanding of the field.

Manuscripts should describe the research concisely and accurately. While there are no page length restrictions, a suggested guideline is around 7,000 words, including the abstract, main text, tables, and legends (excluding references and Supporting Information). References should accurately represent previous theoretical and practical research that has guided the development of the hypothesis and experimental aspects of the work. The abstract should be limited to 300 words, summarizing the research context, key results, and conclusions. Abbreviations and acronyms should only be introduced if essential. Additionally, articles should include 5-7 lowercase keywords and a graphical Table of Contents entry to visually highlight the importance of the research outcomes.

Letter

Letters are short publications that report results whose immediate availability to the science and engineering community is deemed important. Letters are limited to 3,000 words including the abstract, main text, tables, and legends, excluding references. Letters can contain up to 5 figures and 50 references; no section headings are used. Letters should include a graphical Table of Contents entry. Special efforts will be made to expedite the review and the publication of Letters. Therefore, authors of Letters should ensure that manuscripts are in final, error-free form when submitted.

Review

Reviews are comprehensive, critical examinations of a selected topic, typically over a defined period. Reviews are expected to critically evaluate published work of multiple, international groups in a field or across disciplines; be logically organized; be of general interest to the journal readership; and make the material more easily accessible to those not expert in the area through clear text and figures. Reviews should lay out the challenges and opportunities that lie ahead and provide critical discussions that can help move the field forward. Reviews should contain an abstract (≤300 words), a graphical Table of Contents entry, and appropriate references. The use of graphics to illustrate key concepts within the text is strongly encouraged.

A Review should generally not exceed 12,000 words including the abstract, main text, tables, and legends, excluding references. Most Reviews are expected to be substantially shorter in length, although the length should be ultimately dictated by the subject matter. Reviews also include ~5–10 keywords and a vocabulary section in which 5–7 terms extracted from the text are defined in one or two sentences.

While reviews are mostly invited, unsolicited reviews may also be considered. Authors interested in submitting a Review are strongly encouraged to contact the Editors prior to manuscript preparation and submission, to seek conditional approval of the proposed topic. A single document consisting of the following information should be sent to the Editor (eic@cbe.acs.org ) for consideration.

……

更多详情:

https://publish.acs.org/publish/author_guidelines?coden=cbehb5


中国全科医学发文选摘

  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析

《化学工程与生物工程(英文)(Chem & Bio Engineering)(国际刊号)(2026年12月31日之前不收版面费)》同类化学,生物科学期刊

常见问题

  • 哪些期刊可以用来评职称?

    1、期刊要具备正规性和合法性,需在国家新闻出版总署备案,具备国内刊号(cn)。2、期刊要具备学术性,例如该期刊需被国内主流学术、数据库收录,例如被知网,万方,维普收录。具体详情可以咨询我们的客服老师为您解答。

  • 你们的服务可以保证文章被发表吗?

    期刊发表的成功与否,主要取决于文章内容的质量。期刊编辑会根据研究领域、创新性等多因素进行考量。我们会帮助您理解期刊的发表要求,助力提升发表几率,从而增加发表的机会。

  • 请问发表一篇期刊的费用是多少?

    期刊的种类繁多,其费用也各不相同。根据您的需求,将为您推荐最具性价比的期刊,让您能更便捷地找到心仪的期刊。一般来说,只要符合职称评定要求的,大多数作者都会选择性价比最高的期刊作为首选目标。

  • 如果发表不成功可以退款吗?

    如果因为我方原因导致未能发表成功,我们将全额退还相关费用。需要明确的是,稿件能否发表主要取决于期刊的独立考量。为了提升您的发表几率,我们会提供专业的指导和支持,帮助您避免拒稿,并助力提高您的稿件质量。

  • 请问文章发表需要多长时间?

    不同级别的期刊发表时间是不一样的。无论是普刊还是核心期刊,建议您提前准备。普刊需提前3-6个月,而核心期刊需提前一年左右。为确保职称评定流程顺利进行,建议您提前半年到一年进行准备,以免错过申请的最佳时机。

  • 期刊发表能加急见刊吗?

    为了确保顺利发表,建议您提前一些时间进行安排。本站仅提供投稿发表咨询服务,需要用户自己向出版商投稿且没有绿色通道,是否录用一切以出版商通知为准。